What’s New

Billing Codes Decision Could Aid Track-and-Trace Efforts

A Trump administration decision about how biosimilar drugs will be billed could have an important benefit – making it easier to identify which drugs cause

Read More

Advocates Push Back on ICER’s Tardive Dyskinesia Report

  What’s the value of being able to stop involuntary lip smacking, facial grimacing or torso twitching – and the public stigma they cause? This

Read More

Infant Health Summit Spotlights Diversity and Access Disparity

“Man up” isn’t the advice you’d expect to hear at a policy summit on health care access for mothers and infants.  But it’s just what

Read More

The Generation that Ends the Opioid Epidemic

President Donald Trump declared America’s opioid crisis a public health emergency on Thursday, announcing, “We can be the generation that ends the opioid epidemic.”  But

Read More

Movement Disorders Group Explores Impact, Treatment Barriers in New White Paper

Millions of people are affected by neurological conditions known as movement disorders: Parkinson’s disease, essential tremor, tardive dyskinesia and more. A better understanding of these

Read More

Diabetes Patients’ New Challenge: Non-Medical Switching

“Managing diabetes is an all-day, every-day task for millions of Americans,” explains a new video from the Diabetes Policy Collaborative.  But just when patients have

Read More

Drugs, Data & Opioid Policies

America’s drug abuse crisis has reached epic proportions, a recent report from the Centers for Disease Control and Prevention confirms. Drug-related deaths in 2016 alone

Read More

***PRESS RELEASE*** Non-Medical Switching Analysis Finds Higher Health Care Costs After Patients Were Driven to Lower-Cost Drugs

Proposed legislation in Texas would have protected patients’ preexisting prescriptions year after year WASHINGTON – The Institute for Patient Access (IfPA) released a new analysis of

Read More

Why Patients with Skin Conditions Can’t Get Treated

Tens of millions of people across the United States are affected by skin conditions, but not all of them can access the doctors and medications

Read More

“Fast Facts” on Pharmacovigilance Tackles Drug Safety Issues

One in three U.S. drugs may have safety issues, explains a new Fast Facts policy brief from the Institute for Patient Access.   The statistic opens

Read More
Back to Top